Our Medical Affairs organization advances public health by engaging in scientific dialogue with national immunization technical advisory groups and other relevant institutions, health care authorities and regulators to ensure the scientific value of Moderna’s licensed vaccines and candidate therapies is fully realized, understand further unmet medical needs and foster collaboration to further differentiate our portfolio of vaccines. This role is an exciting opportunity to be a critical part of the EMEA Medical Affairs leadership team. Reporting to the VP Medical Affairs, EMEA, the Country Medical Director will be accountable for the proactive and continuous assessment of the dynamics of the external and internal environment, informing and delivering strategic plans to establish and evolve country Medical Affairs teams and ways of working in support of Moderna’s portfolio of licensed vaccines and candidate therapies still in development.
The Country Medical Director is the Senior Medical Leader for Moderna in a cluster of countries typically integrated by a core market (i.e. Germany, France, the UK, Italy, Spain) and a small number of neighboring mid- or small-size markets. (S)he will be responsible for the development and execution of the Medical Affairs strategy for Moderna’s Infectious Disease franchise for the countries in the cluster. (S)he will represent local opportunities, requirements and needs at the regional and/or headquarter level, as appropriate. The Country Medical Director will also drive scientific leadership within the cluster of countries for Moderna’s vaccine portfolio. As part of this effort, (s)he will represent Moderna in external activities and ensure effective interactions with key scientific leaders, public health experts, scientific and medical associations, and health care authorities at national level. To that end, (s)he will coordinate with the European Scientific Director and the VP Medical Affairs EMEA, as appropriate. (S)he will also be accountable for Medical Affairs’ contributions on the medical aspect of submissions for reimbursement, tenders or procurement agreements for Moderna’s portfolio of vaccines across the cluster.
The Country Medical Director will work closely with Pharmacovigilance and Regulatory Affairs to ensure due diligence in these areas in relation to Moderna’s portfolio of licensed vaccines and candidate therapies in development, as needed. To fulfill these objectives, the Country Medical Director will partner and work closely with numerous external and internal stakeholders across Moderna, including global and regional Medical Affairs colleagues, commercial and clinical development.